You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ph CML-CP

Showing 26 - 50 of 3,666
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Withdrawal or Reduction TKIs in CML-CP

Recruiting
  • MMR on 12 Month
  • withdrawal TKIs or halve TKIs
  • Guangzhou, Guangdong, China
    NanfangH
Sep 2, 2021

Chronic Myelogenous Leukemia - Chronic Phase Trial in China (Dasatinib Tablets)

Completed
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Dasatinib Tablets
  • Shenzhen, Guangdong, China
  • +3 more
Jun 11, 2021

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Ascoli Piceno, Italy
  • +21 more
Jan 3, 2022

Iclusig PMS in CML or Ph+ALL Patients

Recruiting
  • Chronic Myeloid Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Busan, Korea, Republic of
    Kosin University Gaspel Hospital
Sep 16, 2021

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

Recruiting
  • Leukemia, Chronic Myelogenous
  • Chongqing City, Chongqing, China
  • +23 more
Jan 18, 2023

Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid

Recruiting
  • CML-CP; Mutation;Suboptimal Response or Failure in TKI
  • Wuhan, Hubei, China
    Weiming Li
May 31, 2021

Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 15, 2022

Chronic Myeloblastic Leukaemia Trial in Spain (Bosutinib)

Completed
  • Chronic Myeloblastic Leukaemia
  • Gran Canaria, Spain
  • +12 more
Apr 28, 2020

Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

Recruiting
  • Healthy (For Part A)
  • Chronic Myeloid Leukemia (for Part B and C)
  • Vodobatinib (K0706) capsules
  • Downey, California
  • +69 more
Dec 7, 2022

CML, Imatinib Trial in Seoul (high-dose imatinib)

Completed
  • CML
  • Imatinib
  • high-dose imatinib
  • Seoul, Korea, Republic of
    Novartis Investigational Site
Mar 9, 2021

Philadelphia Positive (Ph+) Chronic Myeloid Leukemia Trial in Moscow (Nilotinib)

Terminated
Has Results
  • Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
  • Moscow, Russian Federation
    Novartis Investigative Site
Dec 9, 2019

Early Conversion of Dasatinib in CML-CP Patients

Enrolling by invitation
  • Validity and Safety
  • Dasatinib 100 MG
  • Guangzhou, Guangdong, China
    NanfangH
Dec 9, 2020

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

Completed
  • Chronic Myeloid Leukemia
  • ELISA kit
  • Tanta, Egypt
    Tanta University
May 18, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    Aug 13, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase

    Recruiting
    • CML, Chronic Phase; TKI
    • Flumatinib Mesylate
    • Nilotinib Pill
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Feb 1, 2021

    Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    Jan 3, 2022

    Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Chronic Phase Chronic Myeloid Leukemia
    • Duarte, California
    • +27 more
    Dec 7, 2021

    Leukemia Trial in Worldwide (Dasatinib)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +173 more
    Dec 1, 2022

    Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    • Linz, Oberoesterreich, Austria
    • +207 more
    Jun 23, 2021